India has taken a lead in developing vaccines and medicines for diseases common in the developing world: Dr Jitendra Singh
Admin
Jan 28, 2023 11:00
96
Dr Jitendra Singh. iNNCOVACC is the world’s first intranasal COVID19 vaccine to receive approval for the primary 2-dose schedule, and as a heterologous booster dose. It is developed by Bharat Biotech International Limited (BBIL) in collaboration with Biotechnology Industry Research Assistance (BIRAC), a PSU under the Dept of Biotechnology, Ministry of Science and Technology.
